Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Ive never been on gud forum

<< Previous

Bullboard Posts

Next >>

Comment by StockingUp21on Jun 20, 2022 12:00pm

66 Views

Post# 34768925

RE:RE:RE:RE:Ive never been on gud forum

Lol You are the best at what you do

MrMugsy wrote:

StockingUp21 wrote: I thought he was a victim before reading gud board

Exactly - Chi-Chi and his alias Lookingsocluey are no victims.
They'be been told that GUD is going to take years - so play accordingly.
Was even told to use PLB's 19 year growth curve as his guide.
He also knows Goodman asked for 10 years to build it.
Regardless - he's angry he lost money buying at the high.

I think you understand all about that.

: )